Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Rande Is . . . HOME -- Ignore unavailable to you. Want to Upgrade?

To: carepedeum2000 who wrote (51720)	5/25/2001 10:27:24 AM
From: Rande Is	Read Replies (1) \| Respond to of 57584

Warning: Something we hadn't considered. . . Holidility could also work in reverse. Over the past year, more individual investors have turned to short-selling as a means to increase gains than perhaps anytime in history. And this includes momentum players. I know of whole groups of traders [many hundreds] that were momo chasers a year or two ago. . . and are now momo breakers. So, in my opinion, they will also be looking for and finding holidility opportunities. . . .as the day wears on. Rande Is

To: carepedeum2000 who wrote (51720)	5/25/2001 12:36:19 PM
From: HerbVic	Respond to of 57584

Rat Dog News - MediChem Life Sciences (Nasdaq: MCLS chart, msgs)'s ThermoGen protein expression and biocatalysis unit was awarded two patents covering a number of its biocatalysts. These new biocatalysts increase the number of tools MediChem Life Sciences has to synthesize novel pharmaceutical drug leads. MediChem Life Sciences, Inc. is a drug discovery technology and services company that offers a broad range of integrated chemistry R&D capabilities to pharmaceutical and biotechnology companies. siliconinvestor.com